Brightseed and Pharmavite partner to identify phytonutrients via AI
The partnership will utilize Forager AI to target select human biological pathways, and identify new active natural compounds scientifically validated through biomedical processes.
Photo © Shutterstock.com/PabloLagarto
Brightseed (San Francisco, CA), the developer of Forager AI, has partnered with Pharmavite LLC (West Hills, CA) to identify phytonutrients that are currently undiscovered in the plant kingdom. The partnership will utilize Forager to target select human biological pathways, and identify new active natural compounds scientifically validated through biomedical processes.
Forager AI works by mapping the biological relationships between plants and people to infer which molecules in plants may yield the greatest human health benefits. Once the phytonutrients with the highest potential for triggering specific biological mechanisms are identified, Pharmavite will bring the discoveries into the lab for clinical testing and validation in order to support future product claims. According to Brightseed, less than 1% of existing phytonutrients have been identified or studied.
“Pharmavite has long been the industry leader in bringing high-quality new products to market and in recent years, we’ve accelerated our innovation pipeline exponentially. This new partnership with Brightseed combines the power of AI with our deep scientific expertise and has the potential to be one of the most exciting research relationships in the vitamins and supplements space,” said Tobe Cohen, chief growth officer, Pharmavite, in a press release. “We can’t wait to see what exciting compounds we can identify that may help improve the health and wellness of consumers in new, unexpected ways.”
“Our partnership with Pharmavite represents a category shift that delivers on consumer needs for natural, plant-based solutions that really work,” said Jim Flatt, PhD, Brightseed co-founder and CEO. "With Forager's AI-enabled insights and industry-leading phytonutrient library mapped to human health targets, we are developing an entirely new category of wellness solutions.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
